Dr. Robert Wake is Chairman of the Department of Urology at the University of Tennessee Health Science Center. He completed his Medical School at the University of Tennessee in 1985 where he received the honor of being elected to the Alpha Omega Alpha (AOA) medical society. He then completed his Urology residency at the University of Tennessee in 1990. After this residency, he joined the faculty at UT and has served as Program Director and Vice-Chairman prior to his current position.

Dr. Wake has a special interest in the treatment and research of prostate cancer and its complications, as well as kidney stone disease. Dr. Wake was also one of the first to perform and report on a large series of 2nd generation Targeted Cryoablation of the Prostate.

“With the framework set up at the East Campus, we are well on the way to creating comprehensive men’s health services. We want to provide a friendly and comfortable environment where men can come in for most of their health concerns, from blood pressure and cholesterol to erectile dysfunction or prostate issues, and be cared for by providers who will address those concerns with them.”  – Dr. Wake

Early and accurate detection of prostate cancer is a vital component to a positive prognosis. Regional One Health is now using a new technology to diagnosis prostate tumors that were previously missed using the standard prostate biopsy technique. Previously the prostate biopsy procedure was just a random sampling of the peripheral zones of the prostate hoping to identify prostate cancer that could not be seen by ultrasound.

This new procedure is available at Regional One Health and is being performed by Robert Wake, MD, a urologist with UT Regional One Physicians and Chairman of the Department of Urology at the University of Tennessee Health Science Center. Dr. Wake is a respected leader in the field of urology and has a special interest in the treatment and research of prostate cancer and its complications.